An NCATS Deal

Mar 15, 2012

Eli Lilly has a new partnership with the US National Center for Advancing Translational Sciences, reports the Nature News Blog. Lilly is going to screen more than 3,800 approved and investigational drugs that are part of the center's collection, and the company says it will post its results publicly.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Another Cold Case Arrest

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

Circumventing that Pesky Poison

NPR reports that some insect pests are now becoming resistant to Bt crops.

Not Convened

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

Nature Papers Describe Future Path for Human Genomic Research, Method to Analyze RNA Structure With Nanopore Sequencing, More

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.

Menu

An NCATS Deal

To read the full story....

Breaking News

Bio-Rad Q3 Revenues Jump 15 Percent

CareDx Q3 Revenues Up 58 Percent

Illumina Q3 Revenues Down 12 Percent

Quidel Q3 Revenues Nearly Triple, Beat Analyst Expectations

Ancient Dog Genomes Highlight Close Relationship Between Canines, Humans

Humana Broadens Coverage of NIPT for Average Risk Pregnancies

The Scan

Another Cold Case Arrest

Circumventing that Pesky Poison

Not Convened

Nature Papers Describe Future Path for Human Genomic Research, Method to Analyze RNA Structure With Nanopore Sequencing, More

Sponsorships